If you registered for the original October 14 date, please register again for the new date!
Join us on November 25 for an interactive discussion on how early TPP decisions can help set your program up for a clearer path from bench to bedside.
For early-stage biotech companies, a Target Product Profile (TPP) is a powerful tool for shaping development strategy, communicating the value of a program, and aligning stakeholders around what success looks like.
This session will explore:
How TPPs should evolve as a program moves from early discovery toward clinical development
What founders and development teams should be thinking about early on
How to build a TPP, identify the key assumptions and evidence that will matter later, and anticipate potential development pitfalls before they become costly to address
Due to the limited space of the venue, all registered attendees must be approved and priority goes to Biotechnology companies participating in our competitive accelerator programs.
This is an in-person event only.